Danaher Corporation (DHR) Position Boosted by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its position in shares of Danaher Corporation (NYSE:DHR) by 2.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,859,891 shares of the conglomerate’s stock after purchasing an additional 51,495 shares during the period. Danaher Corporation comprises about 3.1% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s investment portfolio, making the stock its 8th biggest position. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA owned 0.27% of Danaher Corporation worth $159,541,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. National Asset Management Inc. grew its position in shares of Danaher Corporation by 0.4% during the 2nd quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock worth $318,000 after buying an additional 14 shares during the period. First Financial Corp IN grew its position in shares of Danaher Corporation by 0.8% during the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after buying an additional 21 shares during the period. Brighton Jones LLC grew its position in shares of Danaher Corporation by 0.4% during the 2nd quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after buying an additional 21 shares during the period. Guardian Life Insurance Co. of America grew its position in shares of Danaher Corporation by 1.0% during the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after buying an additional 24 shares during the period. Finally, Buckingham Asset Management LLC grew its position in shares of Danaher Corporation by 0.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock worth $488,000 after buying an additional 24 shares during the period. 75.38% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Position Boosted by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA” was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://www.themarketsdaily.com/2017/11/16/danaher-corporation-dhr-position-boosted-by-loring-wolcott-coolidge-fiduciary-advisors-llp-ma.html.

In other Danaher Corporation news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the sale, the chief executive officer now directly owns 271,737 shares in the company, valued at $25,173,715.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Donald J. Ehrlich sold 10,578 shares of the stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the sale, the director now owns 104,621 shares in the company, valued at $9,501,679.22. The disclosure for this sale can be found here. Insiders have sold 279,628 shares of company stock worth $25,304,394 over the last quarter. Corporate insiders own 12.20% of the company’s stock.

Several equities research analysts have recently commented on DHR shares. BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Zacks Investment Research cut shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $93.31.

Danaher Corporation (DHR) opened at $92.42 on Thursday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a one year low of $76.27 and a one year high of $93.38. The company has a market cap of $64,823.45, a PE ratio of 23.96, a P/E/G ratio of 2.22 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. Danaher Corporation’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 earnings per share. research analysts anticipate that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.61%. Danaher Corporation’s payout ratio is 16.52%.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply